Pay in 4 interest-free payments of $5.31 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Mitochondria-targeting dihydroporphyrin e6 NPs for tumor-selective therapy
Freitas, V.M., Hilfenhaus, G., and Iruela-Arispe, M.L., "Metastasis of Circulating Tumor Cells: Speed Matters", Developmental Cell 45 (1): 3-5 (2018)
Overall, somnolence has been reported in 13.7 or 6.3% of patients receiving cetirizine or placebo, respectively
Oct 12 : The FDA greenlit Pfizers Braftovi (encorafenib)/Mektovi (binimetinib) combination for the treatment of adult patients with non-small cell lung cancer (NSCLC) with a BRAF V600E mutation as confirmed by an FDA-approved test
A reduced form of nicotinamide riboside defines a new path for NAD+ biosynthesis and acts as an orally bioavailable NAD+ precursor
US$ 21.42
US$ 22.42
US$ 29.16
US$ 24.45
US$ 28.16
US$ 27.65
